AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AZTherapies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11231
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D for the early prevention of Alzheimer’s disease; and ALZT-OP1a, to treat post stroke cognitive impairment (PSCI). ALZT-OP1 is a combination therapy consisting of two re-engineered drugs, in which drug A inhibits beta-amyloid peptide polymerization, and lowers cytokine production, while drug B inhibits the neuroinflammatory response. AZTherapies is headquartered in Boston, Massachusetts, the US.

AZTherapies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AZTherapies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AZTherapies Raises USD7.7 Million in Venture Financing 10
AZTherapies Raises Additional USD8.4 Million in Venture Financing 11
AZTherapies Raises USD1.6 Million in Venture Financing 12
AZTherapies Raises Additional USD2.9 Million in Venture Financing 13
AZTherapies Raises USD3.6 Million in Venture Financing 14
AZTherapies Raises Additional USD2.3 Million in Venture Financing 15
AZTherapies Raises USD13.8 Million in Venture Financing 16
AZTherapies Raises USD6 Million in Venture Financing 17
AZTherapies Inc – Key Competitors 18
AZTherapies Inc – Key Employees 19
AZTherapies Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Oct 31, 2017: AZTherapies appoints Karen Reeves, MD as President and Chief Medical Officer 21
Clinical Trials 22
Jan 31, 2018: A new publication confirms AZTherapies’s innovative drug combination approach to address the neuroinflammation response via neuro-immunology and amyloid beta accumulation associated with neurodegeneration and Alzheimer’s disease 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
AZTherapies Inc, Pharmaceuticals & Healthcare, Key Facts 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AZTherapies Raises USD7.7 Million in Venture Financing 10
AZTherapies Raises Additional USD8.4 Million in Venture Financing 11
AZTherapies Raises USD1.6 Million in Venture Financing 12
AZTherapies Raises Additional USD2.9 Million in Venture Financing 13
AZTherapies Raises USD3.6 Million in Venture Financing 14
AZTherapies Raises Additional USD2.3 Million in Venture Financing 15
AZTherapies Raises USD13.8 Million in Venture Financing 16
AZTherapies Raises USD6 Million in Venture Financing 17
AZTherapies Inc, Key Competitors 18
AZTherapies Inc, Key Employees 19

List of Figures
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pon Holdings B.V.:企業のM&A・事業提携・投資動向
    Pon Holdings B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pon Holdings B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Iamgold Corporation:企業のM&A・事業提携・投資動向
    Iamgold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iamgold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Banco de Sabadell, S.A.:戦略・SWOT・企業財務分析
    Banco de Sabadell, S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco de Sabadell, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TDC A/S:企業の戦略・SWOT・財務分析
    TDC A/S - Strategy, SWOT and Corporate Finance Report Summary TDC A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Knight Square Holdings Ltd:企業の戦略・SWOT・財務情報
    Knight Square Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Knight Square Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Avanir Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avanir Pharmaceuticals Inc (Avanir) a subsidiary of Otsuka America, Inc. is a biopharmaceutical company which focuses on developing medicines for patients suffering from central nervous system disorders. The company’s lead products include NUEDEXTA (AVP-923), a first-in-class dual N-methyl-D …
  • Daihachi Chemical Industry Co Ltd:企業の戦略的SWOT分析
    Daihachi Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Groupe Bruxelles Lambert SA (GBLB):企業の財務・戦略的SWOT分析
    Groupe Bruxelles Lambert SA (GBLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Innovus Pharmaceuticals Inc (INNV)-製薬・医療分野:企業M&A・提携分析
    Summary Innovus Pharmaceuticals Inc (Innovus Pharmaceuticals), formerly North Horizon Inc is a pharmaceutical company that commercialize, license and develops over-the-counter and consumer healthcare products. The company’s product portfolio comprises BTH testosterone booster; Zestra for female arou …
  • Dover Corporation:企業の戦略・SWOT・財務情報
    Dover Corporation - Strategy, SWOT and Corporate Finance Report Summary Dover Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Genextra Spa:製薬・医療:M&Aディール及び事業提携情報
    Summary Genextra SpA (Genextra) is a therapies developing company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, INT- 777 for metabolic syndrome, mono therapy and diabetes, novel HDAC and HSP90 inhibitors for the treatment of canc …
  • Cesca Therapeutics Inc (KOOL):企業の財務・戦略的SWOT分析
    Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • F. Hoffmann-La Roche Ltd (ROG):医療機器:M&Aディール及び事業提携情報
    Summary F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company, which develops drugs and diagnostics that improve the standard of care in major disease areas. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, hematology, ne …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chang Hwa Commercial Bank, Ltd.:企業の戦略・SWOT・財務情報
    Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • LifeLabs Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeLabsInc (LifeLabs), formerly MDS Diagnostic Services is a laboratory service provider that diagnoses, treats, monitors and prevent diseases in patients. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • STRATA Skin Sciences Inc (SSKN):医療機器:M&Aディール及び事業提携情報
    Summary STRATA Skin Sciences Inc (STRATA) is a seller of therapeutic and aesthetic dermatology products. Its product portfolio comprises XTRAC laser and VTRAC excimer lamp; the STRATAPEN MicroSystems; and Nordlys. XTRAC laser and VTRAC excimer lamp systems are utilized for the treatment of psoriasis …
  • Biocodex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex, is a pharmaceutical company that manufacturs and distributs probiotic drug products. The company provides products such as Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a y …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆